Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

Micell Technologies, Inc. has announced positive data from two clinical studies of its investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), a thin-strut drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating designed to control drug release.



Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES (via PR Newswire)

DURHAM, N.C., Oct. 23, 2012 /PRNewswire/ — Micell Technologies, Inc. today announced positive data from two clinical studies of its investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), a thin-strut drug-eluting stent distinguished by a rapid-absorbing…



published: October 29, 2012 in: Cardio, Clinical Studies/Trials, Congresses and Meetings

Most read

Latest

^